KERI EVANS: Open Payments
NPI 1811351554 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,390 in 72 payments from 19 companies in 2025. Trend: 2023 $331 · 2024 $489 · 2025 $1,390
Food & beverage: $1,390
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $237 |
| GlaxoSmithKline, LLC. | 12 | $213 |
| Novo Nordisk Inc | 12 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $131 |
| PFIZER INC. | 4 | $94 |
| ABBVIE INC. | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Amgen Inc. | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $47 |
Products named: TRELEGY ELLIPTA, FARXIGA, JARDIANCE, Wegovy, Ozempic, Kerendia, NURTEC ODT, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
